| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |